4//SEC Filing
Newton Charles W. 4
Accession 0001415889-25-008517
CIK 0001806952other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:01 PM ET
Size
6.0 KB
Accession
0001415889-25-008517
Insider Transaction Report
Form 4
Newton Charles W.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2025-03-17$0.56/sh+200,000$111,620→ 200,000 total(indirect: By Trust)
Holdings
- 172,725
Common Stock
Footnotes (2)
- [F1]The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.54 to $0.56, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range
- [F2]Shares held by The Charles & Lisa Newton Living Trust. The Reporting Person is co-trustee and co-grantor of The Charles & Lisa Newton Living Trust.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001866219
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 7:01 PM ET
- Size
- 6.0 KB